Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements

作者: Kyungsil Yoon , Lea Pallaroni , Matthew Stoner , Kevin Gaido , Stephen Safe

DOI: 10.1016/S0960-0760(01)00070-X

关键词: EndocrinologyEstrogen receptorAgonistEstrogenMolecular biologyInternal medicineEstrogen receptor alphaNaringeninFulvestrantContext (language use)BiologyResveratrol

摘要: Structure-dependent estrogen receptor alpha (ER alpha) agonist and antagonist activities of synthetic natural estrogenic compounds were investigated in human HepG2, MDA-MB-231 U2 cancer cell lines. Compounds used this study include 4'-hydroxytamoxifen, ICI 182,780, bisphenol-A (BPA), 2',4',6'-trichloro-4-biphenylol (3Cl-PCB-OH), 2',3',4',5'-tetrachloro-4-biphenylol (4Cl-PCB-OH), p-t-octylphenol, p-nonylphenol, naringenin, kepone, resveratrol, 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE). Cells transfected with a construct (pERE(3)) containing three tandem responsive elements (EREs) either wild-type (ER-wt) or variants expressing activation function-1 (ER-AF1) AF-2 (ER-AF2). The ER the mono dihydroxy aromatic are comparable all three-cell lines, whereas kepone resveratrol dependent on context expression variant forms alpha. In contrast, for these highly complex and, exception 3Cl-PCB-OH, inhibited E2-induced action. Results vitro suggest that antiestrogenic activity structurally diverse is complex, consistent published data often give contradictory results compounds.

参考文章(53)
M. Ponglikitmongkol, J. H. White, P. Chambon, Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. The EMBO Journal. ,vol. 9, pp. 2221- 2231 ,(1990) , 10.1002/J.1460-2075.1990.TB07392.X
D. P. McDonnell, B. A. Lieberman, J. Norris, Development of Tissue-Selective Estrogen Receptor Modulators Springer, Berlin, Heidelberg. pp. 1- 28 ,(1995) , 10.1007/978-3-662-09153-1_1
Paul S. Jones, Emma Parrott, Ian N. H. White, Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent Journal of Biological Chemistry. ,vol. 274, pp. 32008- 32014 ,(1999) , 10.1074/JBC.274.45.32008
Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer, Stephen Safe, Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies Molecular Pharmacology. ,vol. 58, pp. 852- 858 ,(2000) , 10.1124/MOL.58.4.852
Alfred W. Brandenberger, Meng Kian Tee, Janet Y. Lee, Victor Chao, Robert B. Jaffe, Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. The Journal of Clinical Endocrinology and Metabolism. ,vol. 82, pp. 3509- 3512 ,(1997) , 10.1210/JCEM.82.10.4400
M T Tzukerman, A Esty, D Santiso-Mere, P Danielian, M G Parker, R B Stein, J W Pike, D P McDonnell, Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Molecular Endocrinology. ,vol. 8, pp. 21- 30 ,(1994) , 10.1210/MEND.8.1.8152428
Eva Enmark, Markku Pelto-Huikko, Kaj Grandien, Svetlana Lagercrantz, Jacob Lagercrantz, Gabriel Fried, Magnus Nordenskjöld, Jan-Åke Gustafsson, Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern The Journal of Clinical Endocrinology and Metabolism. ,vol. 82, pp. 4258- 4265 ,(1997) , 10.1210/JCEM.82.12.4470
Bryan D Lemon, Leonard P Freedman, Nuclear receptor cofactors as chromatin remodelers. Current Opinion in Genetics & Development. ,vol. 9, pp. 499- 504 ,(1999) , 10.1016/S0959-437X(99)00010-6